Other
Endometrioma
0
Pipeline Programs↗
2
Active Trials↗
0
Companies Involved↗
Endometrioma is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
12
clinical trials
Unknown status4 · 33%
Completed3 · 25%
Withdrawn2 · 17%
Recruiting2 · 17%
Suspended1 · 8%
Clinical Trials
Trial Activity
12 trials
Estetrol/Drospirenone to Reduce the Average Size of Endometriomas
Recruiting·—·Phase 4·NCT05837624·21 enrolled
Surgicel Reduces Ovarian Endometriomas Recurrence
Completed·—·Phase 2·NCT02947724·200 enrolled
Trans-vaginal Aspiration of Small Ovarian Endometrioma. Comparison of Two Different Techniques Before ICSI
Unknown status·—·Phase 4·NCT03784404·100 enrolled
Effects of Dienogest and Dienogest Plus Estradiol Valerate in Ovarian Endometrioma
Unknown status·—·Phase 4·NCT03789123·710 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)